3349.T
COSMOS Pharmaceutical Corporation
プライム · 小売業 · 小売 · JP
JPY 6,672.00
+4.02%Year over year
Reported trailing growth
- Revenue
- +6.7%
- EBITDA
- —
- EBIT
- +3.6%
- EPS
- -14.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -1.2%
- EBITDA
- —
- EPS
- -1.2%
Three-year CAGR
- Revenue
- +10.2%
- EBITDA
- +11.7%
- EBIT
- +10.7%
- Net income
- +10.2%
- EPS
- -12.6%
- Free cash flow
- -35.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Feb 1, 2026